InspireMD (NASDAQ: NSPR) reported Q4 EPS of ($0.14), $0.05 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $3.15 million versus the consensus estimate of $2.32 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.